SCHEMBL6533341

SCHEMBL6533341

C=CCNC(C)Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Glycine SCHEMBL633951 0.82 GLRA1 (0.37)
SCHEMBL8416121 0.77 SLC6A4 (0.38)
SCHEMBL4940686 0.77 SLC6A4 (0.38)
SCHEMBL468003 0.77
SCHEMBL4856414 0.75 SLC6A4 (0.40)
SCHEMBL6443497 0.75
Hydrochloric Acid SCHEMBL9255979 0.74
Bromide SCHEMBL28594415 0.74
SCHEMBL277864 0.74
SCHEMBL9446602 0.72 SLC6A4 (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020257487-A1 GLYCOLATE OXIDASE INHIBITORS FOR THE TREATMENT OF DISEASE BIOMARIN PHARMACEUTICAL INC. (US) 2020-12-24 WO disclosed
WO-2005061507-A1 BICYCLIC PYRAZOL-4-ONE CANNABINOID RECEPTOR LIGANDS AND USES THEREOF PFIZER PRODUCTS INC. (US) 2005-07-07 WO disclosed
US-5374772-A Skin disorders, antiinflammatory agents, cardiovascular disorders HOFFMANN-LAROCHE INC. (US) 1994-12-20 US disclosed